Picture of Anavex Life Sciences logo

AVXL Anavex Life Sciences Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Annual balance sheet for Anavex Life Sciences, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

R2018
September 30th
2019
September 30th
2020
September 30th
2021
September 30th
2022
September 30th
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Cash and Short Term Investments22.922.229.2152149
Net Total Receivables1.872.644.859.143.19
Prepaid Expenses
Total Other Current Assets
Total Current Assets26.125.334.5162153
Other Long Term Assets
Total Assets26.225.334.5162153
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities3.885.047.3110.810.2
Total Long Term Debt
Total Debt
Total Liabilities3.885.047.3110.810.2
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity22.320.327.2151142
Total Liabilities & Shareholders' Equity26.225.334.5162153
Total Common Shares Outstanding

Or unlock with your email

Or unlock with your email